Form 8-K - Current report:
SEC Accession No. 0001213900-24-065375
Filing Date
2024-08-06
Accepted
2024-08-06 08:00:17
Documents
30
Period of Report
2024-08-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210679-8k_tffpharma.htm   iXBRL 8-K 26218
2 PRESS RELEASE DATED AUGUST 6, 2024 ea021067901ex99-1_tffpharma.htm EX-99.1 26351
3 THE COMPANY'S INVESTOR PRESENTATION MATERIALS ea021067901ex99-2_tffpharma.htm EX-99.2 22398
4 GRAPHIC ex99-1_001.jpg GRAPHIC 166050
5 GRAPHIC ex99-2_001.jpg GRAPHIC 798476
6 GRAPHIC ex99-2_002.jpg GRAPHIC 821810
7 GRAPHIC ex99-2_003.jpg GRAPHIC 780827
8 GRAPHIC ex99-2_004.jpg GRAPHIC 467440
9 GRAPHIC ex99-2_005.jpg GRAPHIC 463363
10 GRAPHIC ex99-2_006.jpg GRAPHIC 680402
11 GRAPHIC ex99-2_007.jpg GRAPHIC 729206
12 GRAPHIC ex99-2_008.jpg GRAPHIC 264648
13 GRAPHIC ex99-2_009.jpg GRAPHIC 740839
14 GRAPHIC ex99-2_010.jpg GRAPHIC 781375
15 GRAPHIC ex99-2_011.jpg GRAPHIC 577225
16 GRAPHIC ex99-2_012.jpg GRAPHIC 598607
17 GRAPHIC ex99-2_013.jpg GRAPHIC 463627
18 GRAPHIC ex99-2_014.jpg GRAPHIC 716646
  Complete submission text file 0001213900-24-065375.txt   12729477

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE tffp-20240806.xsd EX-101.SCH 3018
20 XBRL LABEL FILE tffp-20240806_lab.xml EX-101.LAB 34240
21 XBRL PRESENTATION FILE tffp-20240806_pre.xml EX-101.PRE 22361
32 EXTRACTED XBRL INSTANCE DOCUMENT ea0210679-8k_tffpharma_htm.xml XML 3786
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 241177156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)